Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
0.7550
-0.0062 (-0.81%)
At close: Apr 16, 2026, 4:00 PM EDT
0.7536
-0.0014 (-0.19%)
After-hours: Apr 16, 2026, 6:31 PM EDT
Mustang Bio Market Cap
Mustang Bio has a market cap or net worth of $5.72 million as of April 16, 2026. Its market cap has increased by 33.03% in one year.
Market Cap
5.72M
Enterprise Value
-11.55M
1-Year Change
33.03%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since August 22, 2017, Mustang Bio's market cap has decreased from $257.00M to $5.72M, a decrease of -97.77%. That is a compound annual growth rate of -35.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 5.70M | -20.83% |
| Dec 31, 2025 | 7.20M | -15.29% |
| Dec 31, 2024 | 8.50M | -31.45% |
| Dec 29, 2023 | 12.40M | -70.75% |
| Dec 30, 2022 | 42.40M | -72.66% |
| Dec 31, 2021 | 155.10M | -37.18% |
| Dec 31, 2020 | 246.90M | 49.18% |
| Dec 31, 2019 | 165.50M | 106.36% |
| Dec 31, 2018 | 80.20M | -74.50% |
| Dec 29, 2017 | 314.50M | 22.37% |
| Aug 22, 2017 | 257.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Purple Biotech | 6.17M |
| XTL Biopharmaceuticals | 6.01M |
| Cardio Diagnostics Holdings | 5.80M |
| Bio Green Med Solution | 5.80M |
| Akari Therapeutics, | 5.79M |
| Ernexa Therapeutics | 5.74M |
| Moolec Science | 5.70M |
| Dermata Therapeutics | 5.43M |